Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Research & Development (2016 - 2025)

Historic Research & Development for Arcadia Biosciences (RKDA) over the last 12 years, with Q2 2025 value amounting to $9000.0.

  • Arcadia Biosciences' Research & Development fell 1000.0% to $9000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $22000.0, marking a year-over-year decrease of 5510.2%. This contributed to the annual value of $53000.0 for FY2024, which is 1718.75% down from last year.
  • According to the latest figures from Q2 2025, Arcadia Biosciences' Research & Development is $9000.0, which was down 1000.0% from $13000.0 recorded in Q4 2024.
  • Arcadia Biosciences' 5-year Research & Development high stood at $1.2 million for Q1 2021, and its period low was $6000.0 during Q1 2024.
  • For the 5-year period, Arcadia Biosciences' Research & Development averaged around $345294.1, with its median value being $255000.0 (2022).
  • Examining YoY changes over the last 5 years, Arcadia Biosciences' Research & Development showed a top increase of 6000.0% in 2024 and a maximum decrease of 9832.87% in 2024.
  • Arcadia Biosciences' Research & Development (Quarter) stood at $561000.0 in 2021, then fell by 10.87% to $500000.0 in 2022, then plummeted by 98.2% to $9000.0 in 2023, then skyrocketed by 44.44% to $13000.0 in 2024, then crashed by 30.77% to $9000.0 in 2025.
  • Its last three reported values are $9000.0 in Q2 2025, $13000.0 for Q4 2024, and $24000.0 during Q3 2024.